Markets & Finance

GrubMarket, a food supply chain technology and distribution company with over 2 billion dollars in 2024 revenue, submitted a confidential S-1 draft to the SEC on July 28, 2026, under JOBS Act provisions that keep financials, underwriters, and offering size undisclosed until roughly 15 days before its road show. The filing comes 18 months after a January 2025 SEC settlement in which the company paid an 8 million dollar civil penalty for materially overstating revenues by more than 550 million dollars during a 2019 to 2021 fundraising period. Key unknowns for prospective investors include detailed GAAP financials, the accounting treatment of roughly 60 to 90 acquisitions, and how the company will frame the SEC enforcement action in its eventual public registration statement.

Shein's Hong Kong IPO prospectus, published July 26, 2026, contains the company's first public acknowledgment that its U.S. operations are under FTC investigation, with the prospectus warning that the outcome could require significant monetary payments and materially affect financial results. The filing also shows Shein is targeting a valuation of US$40–50 billion, down from US$100 billion in 2022, alongside a reported Q1 2026 net loss of approximately US$99 million partly tied to the elimination of the U.S. de minimis tariff exemption. Separately, the European Commission opened a formal Digital Services Act investigation in February 2026 covering illegal product listings, addictive interface design, and recommender system transparency, with potential fines of up to 6 percent of global annual turnover.

GSK reported Q2 2026 turnover of £8.41 billion and core EPS of 50.5 pence, both above consensus, while announcing a three-year cost program targeting £1.9 billion in annual run-rate savings by 2029 at a one-time implementation cost of £2.4 billion. The savings, drawn roughly 45% from procurement, 40% from reallocating resources away from mature products, and 15% from supply-chain changes, are intended to fund a doubling of Phase III clinical trial starts to more than 20 in 2026. The program is explicitly designed to offset anticipated revenue pressure from the loss of exclusivity on dolutegravir, GSK's core HIV drug, beginning in the US in April 2028.

Porsche AG posted €1.35 billion in operating profit for H1 2026, a 33.9% increase despite a 5.1% drop in revenue to €17.23 billion, as tighter cost and pricing discipline lifted its operating margin from 5.5% to 7.8%. The company simultaneously signed a workforce agreement to eliminate roughly 9,000 positions by 2035, about one in five global roles, while guaranteeing no compulsory redundancies and committing €2.1 billion in site investment. Full-year guidance was reaffirmed, contingent on current tariff conditions holding, even as vehicle deliveries fell 16% globally and 32% in China.

A KKR and Energy Capital Partners consortium agreed on July 27, 2026 to acquire Irish-incorporated energy distributor DCC Energy at 6,525 pence per share in cash, representing a 39% premium to the April 30 undisturbed price when combined with a previously paid dividend. The deal, structured as an Irish scheme of arrangement with an enterprise value of approximately £7.68 billion, is the third offer after earlier bids were rejected or opposed by major shareholders including Fidelity International and Aviva Investors. Shareholders may receive up to an additional 125 pence per share contingent on DCC Energy completing a sale of its Nexora technology unit, though no binding agreement for that sale existed at announcement.

LendingTree's Q2 2026 earnings release arrives after today's market close, following a Q1 in which total revenue rose 37% year-over-year to $327.3 million, led by a record $221.9 million Insurance segment that now accounts for roughly 64% of company revenue. The Home segment remains under pressure as the 30-year fixed mortgage rate reached 6.58% in late July 2026, while revolving consumer credit contracted at a 4.7% annualized rate in May. Investors will focus on whether Insurance carrier demand held through Q2 and whether management issues a second consecutive upward revision to full-year 2026 guidance, which currently targets $1.30–$1.35 billion in revenue.